Nikhil Lalwani - Mar 7, 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Mar 7, 2025
Transactions value $
-$1,034,177
Form type
4
Date filed
3/14/2025, 05:20 PM
Previous filing
Mar 4, 2025
Next filing
Mar 25, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability -$1.03M -17.1K -3.39% $60.62 486K Mar 7, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported.